- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02327611
CUstodiol Versus RInger: whaT Is the Best Agent?
CUstodiol Versus RInger: whaT Is the Best Agent? A Randomized Double Blind Trial.
Postoperative renal failure is the most significant risk factor for early mortality after elective surgical repair of thoracoabdominal aortic aneurysms (TAAAs).
To prevent damages related to kidney ischemia during aortic crossclamping and TAAA repair, the most recent guidelines recommend the use of cold crystalloid or blood perfusion. Since the most studied crystalloid solution is the Ringer's lactate solution, this can be considered the standard of care for evaluating the effectiveness of other substrates.
An histidine-tryptophan-ketoglutarate enriched crystalloid solution named Custodiol (Dr. Franz Kohler Chemie GmbH, Bensheim, Germany) is currently used for organ preservation during transplantation and for cardioplegia during open-heart surgery in most EU countries. This solution may provide a better grade of renal protection to ischemic damage than the standard crystalloid solutions.
A recent observational study published by our group suggested a lower incidence of postoperative renal kidney injury in patients undergoing open TAAA surgical repair using renal perfusion with Custodiol, as compared to those perfused with an enriched Ringer's lactate solution.
Objective of this study is the confirmation of the promising findings about the effectiveness of renal perfusion with Custodiol during repair of TAAA compared with other crystalloid.
The study will be a prospective, single-center, randomized, double-blind, controlled trial, investigating Acute Kidney Injury in patients undergoing TAAA open repair using Custodiol renal perfusion versus an enriched Ringer's lactate solution. It is expected to enroll adult patients undergoing elective TAAA open repair. Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Milano, Italy, 20132
- San Raffaele Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Ability to provide written informed consent; Patient undergoing open surgical repair of TAAA requiring renal perfusion.
Exclusion Criteria:
- Patients who have participated to experimental trials during the previous 3 months
- Intervention under emergency / urgency
- Patient uncooperative and / or affected by mental disease
- Allergy or intolerance to the study drug
- Patient under renal replacement treatment (dialysis) before surgery
- Pregnant or breast-feeding women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Custodiol
Renal perfusion with Custodiol (cold crystalloid solution enriched with histidine-tryptophan-ketoglutarate).
|
|
Active Comparator: enriched Ringer's lactate solution
Renal perfusion with cold Ringer's lactate solution enriched with methylprednisolone 125 mg /L and mannitol 12.5 g /L.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Acute Kidney Injury
Time Frame: Kidney function will be assessed during hospital stay (an expected average of 2 weeks)
|
Kidney function will be assessed during hospital stay (an expected average of 2 weeks)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CURITIBA/9/OSR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracoabdominal Aortic Aneurysms
-
Gustavo OderichCook Group IncorporatedRecruitingJuxtarenal Aortic Aneurysms | Suprarenal Aortic Aneurysms | Type IV Thoracoabdominal Aortic AneurysmsUnited States
-
University of South FloridaMedtronic; Sanford HealthActive, not recruiting
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingThoracoabdominal Aortic AneurysmsChina
-
NYU Langone HealthCompletedThoracoabdominal Aortic AneurysmsUnited States
-
IRCCS San RaffaeleCompletedThoracoabdominal Aneurysms and Para-renal Aortic AneurysmsItaly
-
Lifetech Scientific (Shenzhen) Co., Ltd.Unknown
-
Sanford HealthActive, not recruitingThoracoabdominal AneurysmsUnited States
-
IRCCS San RaffaeleCompletedThoracoabdominal Aortic AneurysmsItaly
-
IRCCS San RaffaeleCompletedAortic Aneurysm, Thoracoabdominal | Para-renal Aortic AneurysmsItaly
-
The Christ HospitalMedtronicRecruiting
Clinical Trials on Custodiol
-
Dr. F. Köhler Chemie GmbHCompletedCoronary Artery Disease (CAD)Germany
-
Dr. F. Köhler Chemie GmbHCompletedAortic Valve Disease | Coronary Artery Disease (CAD)Germany
-
Dr. F. Köhler Chemie GmbHCompletedHeart FailureAustria, Germany
-
Dr. F. Köhler Chemie GmbHActive, not recruiting
-
Dr. F. Köhler Chemie GmbHRecruitingKidney Failure | Liver Failure, Chronic | Kidney-Pancreas FailureAustria
-
Centre Hospitalier Universitaire de Saint EtienneJazz Pharmaceuticals; Association AIRE (FR)Completed
-
Rigshospitalet, DenmarkLundbeck FoundationCompleted
-
King Faisal Specialist Hospital & Research Centre...CompletedCongenital Heart DiseaseSaudi Arabia
-
Fayoum University HospitalCompletedCardioplegia Solution Adverse ReactionEgypt
-
Republican Scientific and Practical Center for...CompletedLiver Transplantation | Early Allograft Dysfunction | Ischemic Reperfusion Injury | HyperfibrinolysisBelarus